▶ 調査レポート

組み換え因子Cアッセイ(rFC)の世界市場2019-2027:ブランド別(PyroGene [PyroGene Bulk rFC {2,880テスト}、PyroGene rFC {192テスト}]、EndoNext[EndoZyme II、EndoZyme II GO、EndoLisa])、エンドユーザー別

• 英文タイトル:Recombinant Factor C Assay Market (Brand: PyroGene [PyroGene Bulk rFC {2,880 Tests} and PyroGene rFC {192 Tests}] and EndoNext [EndoZyme II, EndoZyme II GO, and EndoLisa]; and End User: Pharmaceutical Companies, Biotechnology Companies, Medical Device Companies, and Contract Research Organizations [CROs]) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 - 2027

Transparency Market Researchが調査・発行した産業分析レポートです。組み換え因子Cアッセイ(rFC)の世界市場2019-2027:ブランド別(PyroGene [PyroGene Bulk rFC {2,880テスト}、PyroGene rFC {192テスト}]、EndoNext[EndoZyme II、EndoZyme II GO、EndoLisa])、エンドユーザー別 / Recombinant Factor C Assay Market (Brand: PyroGene [PyroGene Bulk rFC {2,880 Tests} and PyroGene rFC {192 Tests}] and EndoNext [EndoZyme II, EndoZyme II GO, and EndoLisa]; and End User: Pharmaceutical Companies, Biotechnology Companies, Medical Device Companies, and Contract Research Organizations [CROs]) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 - 2027 / TMR2006032資料のイメージです。• レポートコード:TMR2006032
• 出版社/出版日:Transparency Market Research / 2020年3月
• レポート形態:英文、PDF、172ページ
• 納品方法:Eメール
• 産業分類:医療
• 販売価格(消費税別)
  Single User¥770,735 (USD5,795)▷ お問い合わせ
  Multi User¥1,169,735 (USD8,795)▷ お問い合わせ
  Corporate License¥1,568,735 (USD11,795)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートでは、組み換え因子Cアッセイ(rFC)の世界市場について、序論、仮定、調査手法、エグゼクティブサマリー、市場動向、キーインサイト、ブランド別(PyroGene [PyroGene Bulk rFC {2,880テスト}、PyroGene rFC {192テスト}]、EndoNext[EndoZyme II、EndoZyme II GO、EndoLisa])分析、エンドユーザー別分析、地域別(北米、ヨーロッパ、アジア太平洋、中南米、中東アフリカ)分析、競争状況などを総合的に調査・分析して掲載しております。
・序論
・仮定
・調査手法
・エグゼクティブサマリー
・市場動向
・キーインサイト
・組み換え因子Cアッセイ(rFC)の世界市場規模:ブランド別(PyroGene [PyroGene Bulk rFC {2,880テスト}、PyroGene rFC {192テスト}]、EndoNext[EndoZyme II、EndoZyme II GO、EndoLisa])
・組み換え因子Cアッセイ(rFC)の世界市場規模:エンドユーザー別
・組み換え因子Cアッセイ(rFC)の世界市場規模:地域別(北米、ヨーロッパ、アジア太平洋、中南米、中東アフリカ)
・競争状況

Recombinant Factor C Assay Market – Scope of the Report

TMR’s report on the global recombinant factor C assay market studies the past as well as current growth trends and opportunities to gain valuable insights of these indicators for the global market during the forecast period i.e. from 2019 to 2027. The report provides the overall revenue of the global recombinant factor C assay market for the 2017–2027 period, considering 2018 as the base year and 2027 as the forecast year. The report also provides the compounded annual growth rate (CAGR) for the global recombinant factor C assay market for the forecast period.

The report has been prepared after an extensive research. Primary research involved bulk of research efforts, wherein analysts carried out interviews with market leaders and opinion makers. Extensive secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the global recombinant factor C assay market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts also employed a combination of top-down and bottom-up approaches to study various phenomena in the global recombinant factor C assay market.

The report includes an elaborate executive summary, along with a snapshot of the growth pattern of various segments and sub-segments included in the scope of the study. Additionally, the report sheds light on the changing competition dynamics in the global recombinant factor C assay market. These indices serve as valuable tools for existing market players as well as for entities interested in participating in the global recombinant factor C assay market. The next section of the report highlights the USPs, which include value chain analysis, key industry developments, patent analysis, regulatory scenario, and institutes involved in research studies using horseshoe crabs in the global recombinant factor C assay market.

The report delves into the competition landscape of the global recombinant factor C assay market. Key players operating in the global recombinant factor C assay market have been identified and each one of these has been profiled for its distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players profiled in the global recombinant factor C assay market report.

Key Questions Answered in Global Recombinant Factor C Assay Market Report

How much sales revenue would be generated by recombinant factor C assay across all regions during the forecast period?
What are key trends in the global recombinant factor C assay market?
What are major drivers, restraints, and opportunities in the global recombinant factor C assay market?
Which regional market is set to expand at the most rapid CAGR during the forecast period?
Which end user segment would generate the maximum revenue by 2027 and which brand segment would expand at the most rapid CAGR during the forecast period?
Recombinant Factor C Assay Market – Research Objectives and Research Approach

The comprehensive report on the global recombinant factor C assay market begins with an overview of the market, followed by the scope and objectives of the study. Following this, the report provides detailed explanation of the objectives of the study and health care compliances laid down by accredited agencies in the purview of research in the global recombinant factor C assay market. It is followed by market introduction, market dynamics, and an overview of the global recombinant factor C assay market, which includes TMR’s analysis of market drivers, restraints, and trends affecting the market. Furthermore, Y-o-Y growth analysis with elaborate insights has been provided to understand the Y-o-Y growth trends of the global market. The next section of the global recombinant factor C assay market report highlights the USPs, which include regulatory scenarios for recombinant factor C assay globally, market value chain analysis, and developments in the global market.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section further divided into small sections. The entire report comprises an exhaustive collection of graphs and tables that are appropriately interspersed in the entire compilation. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of market shares of key segments in the past and at the end of the forecast period.

Revenue generated by key players in the global recombinant factor C assay market has been mapped to ascertain the size of the global recombinant factor C assay market, in terms of value. The forecast presented here assesses the total revenue generated in the global recombinant factor C assay market. In order to provide an accurate forecast, we initiated by sizing up the current recombinant factor C assay market with the help of the parent market.

The report analyzes the global recombinant factor C assay market in terms of brand, end user, and region. Key segments under each criteria have been studied at length and the market share for each of these by the end of 2027 has been provided. These valuable insights would help market stakeholders in making informed business decisions for investments in the global recombinant factor C assay market.

レポート目次

1. Preface

1.1. Market Definition and Scope

1.2. Market Segmentation

1.3. Key Research Objectives

1.4. Research Highlights

2. Assumptions and Acronyms

3. Research Methodology

4. Executive Summary: Global Recombinant Factor C Assay Market

5. Market Overview

5.1. Definition

5.2. Market Indicators

5.3. Market Dynamics

5.3.1. Drivers

5.3.2. Restraints

5.3.3. Opportunities

5.4. Global Recombinant Factor C Assay Market Revenue (US$ Mn) Forecast 2017–2027

5.5. Global Recombinant Factor C Assay Market Outlook

6. Key Insights

6.1. Value Chain Analysis

6.2. Key Industry Events

6.3. Patent Analysis

6.4. Product Features & USPs

6.5. Overview of Pyrogen Testing Products Market

6.5.1. Pyrogen Testing- Service Providers

6.5.2. Pyrogen Testing Products Marketing, by Country/Region

6.6. Overview of Limulus Amoebocyte Lysate (LAL) Tests

6.6.1. Number of Assays Performed

6.6.2. Cost per Assay and Turn Around Time

6.7. Regulatory Scenario, by Country/Region

6.8. Institutes Involved in Research Studies using Horseshoe Crabs

7. Global Recombinant Factor C Assay Market Analysis and Forecast, by Brand

7.1. Introduction

7.2. Global Recombinant Factor C Assay Market Value Share Analysis, by Brand

7.3. Global Recombinant Factor C Assay Market Value Forecast, by Brand, 2017–2027

7.3.1. PyroGene

7.3.1.1. PyroGene Bulk rFC (2,880 tests)

7.3.1.2. PyroGene rFC (192 tests)

7.3.2. EndoNext

7.3.2.1. Endozyme II

7.3.2.2. Endozyme II GO

7.3.2.3. EndoLisa

7.4. Global Recombinant Factor C Assay Market Attractiveness, by Brand

8. Global Recombinant Factor C Assay Market Analysis and Forecast, by End-user

8.1. Introduction

8.2. Global Recombinant Factor C Assay Market Value Share Analysis, by End-user

8.3. Global Recombinant Factor C Assay Market Value Forecast, by End-user, 2017–2027

8.3.1. Pharmaceutical Companies

8.3.2. Biotechnology Companies

8.3.3. Medical Device Companies

8.3.4. Contract Research Organizations (CROs)

8.4. Global Recombinant Factor C Assay Market Attractiveness, by End-user

9. Global Recombinant Factor C Assay Market Analysis and Forecast, by Region

9.1. Regional Outlook

9.2. Introduction

9.3. Global Recombinant Factor C Assay Market Value Forecast, by Region

9.3.1. North America

9.3.2. Europe

9.3.3. Asia Pacific

9.3.4. Latin America

9.3.5. Middle East & Africa

9.4. Global Recombinant Factor C Assay Market Attractiveness, by Region

10. North America Recombinant Factor C Assay Market Analysis and Forecast

10.1. Key Findings

10.2. North America Recombinant Factor C Assay Market Value Forecast, by Brand, 2017–2027

10.2.1. PyroGene

10.2.1.1. PyroGene Bulk rFC (2,880 tests)

10.2.1.2. PyroGene rFC (192 tests)

10.2.2. EndoNext

10.2.2.1. Endozyme II

10.2.2.2. Endozyme II GO

10.2.2.3. EndoLisa

10.3. North America Recombinant Factor C Assay Market Value Forecast, by End-user, 2017–2027

10.3.1. Pharmaceutical Companies

10.3.2. Biotechnology Companies

10.3.3. Medical Device Companies

10.3.4. Contract Research Organizations (CROs)

10.4. North America Recombinant Factor C Assay Market Value Forecast, by Country, 2017–2027

10.4.1. U.S.

10.4.2. Canada

10.5. North America Recombinant Factor C Assay Market Attractiveness Analysis

10.5.1. By Brand

10.5.2. By End-user

10.5.3. By Country

11. Europe Recombinant Factor C Assay Market Analysis and Forecast

11.1. Key Findings

11.2. Europe Recombinant Factor C Assay Market Value Forecast, by Brand, 2017–2027

11.2.1. PyroGene

11.2.1.1. PyroGene Bulk rFC (2,880 tests)

11.2.1.2. PyroGene rFC (192 tests)

11.2.2. EndoNext

11.2.2.1. Endozyme II

11.2.2.2. Endozyme II GO

11.2.2.3. EndoLisa

11.3. Europe Recombinant Factor C Assay Market Value Forecast, by End-user, 2017–2027

11.3.1. Pharmaceutical Companies

11.3.2. Biotechnology Companies

11.3.3. Medical Device Companies

11.3.4. Contract Research Organizations (CROs)

11.4. Europe Recombinant Factor C Assay Market Value Forecast, by Country/Sub-region, 2017–2027

11.4.1. U.K.

11.4.2. Germany

11.4.3. France

11.4.4. Italy

11.4.5. Spain

11.4.6. Rest of Europe

11.5. Europe Recombinant Factor C Assay Market Attractiveness Analysis

11.5.1. By Brand

11.5.2. By End-user

11.5.3. By Country/Sub-region

12. Asia Pacific Recombinant Factor C Assay Market Analysis and Forecast

12.1. Key Findings

12.2. Asia Pacific Recombinant Factor C Assay Market Value Forecast, by Brand, 2017–2027

12.2.1. PyroGene

12.2.1.1. PyroGene Bulk rFC (2,880 tests)

12.2.1.2. PyroGene rFC (192 tests)

12.2.2. EndoNext

12.2.2.1. Endozyme II

12.2.2.2. Endozyme II GO

12.2.2.3. EndoLisa

12.3. Asia Pacific Recombinant Factor C Assay Market Value Forecast, by End-user, 2017–2027

12.3.1. Pharmaceutical Companies

12.3.2. Biotechnology Companies

12.3.3. Medical Device Companies

12.3.4. Contract Research Organizations (CROs)

12.4. Asia Pacific Recombinant Factor C Assay Market Value Forecast, by Country/Sub-region, 2017–2027

12.4.1. China

12.4.2. India

12.4.3. Japan

12.4.4. Australia & New Zealand

12.4.5. Rest of Asia Pacific

12.5. Asia Pacific Recombinant Factor C Assay Market Attractiveness Analysis

12.5.1. By Brand

12.5.2. By End-user

12.5.3. By Country/Sub-region

13. Latin America Recombinant Factor C Assay Market Analysis and Forecast

13.1. Key Findings

13.2. Latin America Recombinant Factor C Assay Market Value Forecast, by Brand, 2017–2027

13.2.1. PyroGene

13.2.1.1. PyroGene Bulk rFC (2,880 tests)

13.2.1.2. PyroGene rFC (192 tests)

13.2.2. EndoNext

13.2.2.1. Endozyme II

13.2.2.2. Endozyme II GO

13.2.2.3. EndoLisa

13.3. Latin America Recombinant Factor C Assay Market Value Forecast, by End-user, 2017–2027

13.3.1. Pharmaceutical Companies

13.3.2. Biotechnology Companies

13.3.3. Medical Device Companies

13.3.4. Contract Research Organizations (CROs)

13.4. Latin America Recombinant Factor C Assay Market Value Forecast, by Country/Sub-region, 2017–2027

13.4.1. Brazil

13.4.2. Mexico

13.4.3. Rest of Latin America

13.5. Latin America Recombinant Factor C Assay Market Attractiveness Analysis

13.5.1. By Product

13.5.2. By End-user

13.5.3. By Country/Sub-region

14. Middle East & Africa Recombinant Factor C Assay Market Analysis and Forecast

14.1. Key Findings

14.2. Middle East & Africa Recombinant Factor C Assay Market Value Forecast, by Brand, 2017–2027

14.2.1. PyroGene

14.2.1.1. PyroGene Bulk rFC (2,880 tests)

14.2.1.2. PyroGene rFC (192 tests)

14.2.2. EndoNext

14.2.2.1. Endozyme II

14.2.2.2. Endozyme II GO

14.2.2.3. EndoLisa

14.3. Middle East & Africa Recombinant Factor C Assay Market Value Forecast, by End-user, 2017–2027

14.3.1. Pharmaceutical Companies

14.3.2. Biotechnology Companies

14.3.3. Medical Device Companies

14.3.4. Contract Research Organizations (CROs)

14.4. Middle East & Africa Recombinant Factor C Assay Market Value Forecast, by Country/Sub-region, 2017–2027

14.4.1. GCC Countries

14.4.2. South Africa

14.4.3. Rest of Middle East & Africa

14.5. Middle East & Africa Recombinant Factor C Assay Market Attractiveness Analysis

14.5.1. By Product

14.5.2. By End-user

14.5.3. By Country/Sub-region

15. Competition Landscape

15.1. Company Share Analysis

15.2. Company Profiles

15.2.1. Lonza Group

15.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)

15.2.1.2. Financial Overview

15.2.1.3. Product Portfolio

15.2.1.4. Strategic Overview

15.2.1.5. SWOT Analysis

15.2.2. Hyglos GmbH – a bioMérieux Company

15.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)

15.2.2.2. Financial Overview

15.2.2.3. Product Portfolio

15.2.2.4. Strategic Overview

15.2.2.5. SWOT Analysis

List of Tables

Table 01: Patent Information – Pyrogene (Lonza)

Table 02: Patent Information – EndoLisa

Table 03: Patent Information – EndoZyme II GO

Table 04: Patent Information – Recombinant Factor C Assay Market

Table 05: Product Features & USPs – Recombinant Factor C Assays

Table 06: Pyrogen Testing- Service Providers

Table 07: Pyrogen Testing- Service Providers

Table 08: Pyrogen Testing Products Marketing

Table 09: Cost per Assay and Turn Around Time (LAL)

Table 10: Institutes Involved in Research Studies using Horseshoe Crabs

Table 11: Institutes Focused on Conversing Horseshoe Crabs

Table 12: Pyrogen Testing Market Offerings, By Company

Table 13: Global Recombinant Factor C Assay Market Value (US$ Thousand) Forecast, by Brand, 2017–2027

Table 14: Global Recombinant Factor C Assay Market Value (US$ Thousand) Forecast, by PyroGene, 2017–2027

Table 15: Global Recombinant Factor C Assay Market Value (US$ Thousand) Forecast, by EndoNext, 2017–2027

Table 16: Global Recombinant Factor C Assay Market Value (US$ Thousand) Forecast, by End-user, 2017–2027

Table 17: Global Recombinant Factor C Assay Market Value (US$ Thousand) Forecast, by Region, 2017–2027

Table 18: North America Recombinant Factor C Assay Market Value (US$ Thousand) Forecast, by Country, 2017–2027

Table 19: North America Recombinant Factor C Assay Market Value (US$ Thousand) Forecast, by Brand, 2017–2027

Table 20: North America Recombinant Factor C Assay Market Value (US$ Thousand) Forecast, by PyroGene, 2017–2027

Table 21: North America Recombinant Factor C Assay Market Value (US$ Thousand) Forecast, by EndoNext, 2017–2027

Table 22: North America Recombinant Factor C Assay Market Value (US$ Thousand) Forecast, by End-user, 2017–2027

Table 23: Europe Recombinant Factor C Assay Market Value (US$ Thousand) Forecast, by Country/Sub-region, 2017–2027

Table 24: Europe Recombinant Factor C Assay Market Value (US$ Thousand) Forecast, by Brand, 2017–2027

Table 25: Europe Recombinant Factor C Assay Market Value (US$ Thousand) Forecast, by PyroGene, 2017–2027

Table 26: Europe Recombinant Factor C Assay Market Value (US$ Thousand) Forecast, by EndoNext, 2017–2027

Table 27: Europe Recombinant Factor C Assay Market Value (US$ Thousand) Forecast, by End-user, 2017–2027

Table 28: Asia Pacific Recombinant Factor C Assay Market Value (US$ Thousand) Forecast, by Country/Sub-region, 2017–2027

Table 29: Asia Pacific Recombinant Factor C Assay Market Value (US$ Thousand) Forecast, by Brand, 2017–2027

Table 30: Asia Pacific Recombinant Factor C Assay Market Value (US$ Thousand) Forecast, by PyroGene, 2017–2027

Table 31: Asia Pacific Recombinant Factor C Assay Market Value (US$ Thousand) Forecast, by EndoNext, 2017–2027

Table 32: Asia Pacific Recombinant Factor C Assay Market Value (US$ Thousand) Forecast, by End-user, 2017–2027

Table 33: Latin America Recombinant Factor C Assay Market Value (US$ Thousand) Forecast, by Country/Sub-region, 2017–2027

Table 34: Latin America Recombinant Factor C Assay Market Value (US$ Thousand) Forecast, by Brand, 2017–2027

Table 35: Latin America Recombinant Factor C Assay Market Value (US$ Thousand) Forecast, by PyroGene, 2017–2027

Table 36: Latin America Recombinant Factor C Assay Market Value (US$ Thousand) Forecast, by EndoNext, 2017–2027

Table 37: Latin America Recombinant Factor C Assay Market Value (US$ Thousand) Forecast, by End-user, 2017–2027

Table 38: Middle East & Africa Recombinant Factor C Assay Market Value (US$ Thousand) Forecast, by Country/Sub-region, 2017–2027

Table 39: Middle East & Africa Recombinant Factor C Assay Market Value (US$ Thousand) Forecast, by Brand, 2017–2027

Table 40: Middle East & Africa Recombinant Factor C Assay Market Value (US$ Thousand) Forecast, by PyroGene, 2017–2027

Table 41: Middle East & Africa Recombinant Factor C Assay Market Value (US$ Thousand) Forecast, by EndoNext, 2017–2027

Table 42: Middle East & Africa Recombinant Factor C Assay Market Value (US$ Thousand) Forecast, by End-user, 2017–2027